Posted on 05/23/2022 6:08:49 AM PDT by deport
In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old.
The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The trial wasn't big enough to estimate protection against severe disease, which experts expect to be higher.
The news doesn’t change the overall timeline for when vaccines for this age group could be available. For the youngest Americans, vaccines from both Pfizer and Moderna are expected to be authorized in June or July, likely as a three-dose vaccine for Pfizer and a two-dose vaccine for Moderna, though Moderna is also studying a third dose.
(Excerpt) Read more at abcnews.go.com ...
COVID boosters offered for ages 5-11 at Steuben clinics
Note that you still can't get one from your local pediatrician.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.